FeaturedPortfolio news Alentis Therapeutics receives FDA Fast Track Designation for ALE.C04 We are pleased to announce that Alentis Therapeutics, a company within our portfolio, has been granted fast track designation by the US FDA for its…cherin13.09.2023
